The National Institutes of Health has awarded a two-year, $420,025 grant to Professor Charles Roth for an R21 project entitled "Surface Active Polyelectrolyte Nanomedicine for Treatment of Lung Infections in Cystic Fibrosis." The goal of the project is to develop aerosolized nanomedicines that can penetrate mucus and biofilms in the lungs of cystic fibrosis patients for improved delivery and antibiotic efficacy.